{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:03:25Z","timestamp":1794017005669,"version":"4.8.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":4687,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2003,2]]},"DOI":"10.1046\/j.1523-1747.2003.12040.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:05:33Z","timestamp":1047449133000},"page":"211-216","source":"Crossref","is-referenced-by-count":318,"title":["Risk of Malignancies in Psoriasis Patients Treated with Cyclosporine: a 5 y Cohort Study"],"prefix":"10.1016","volume":"120","author":[{"given":"Carle F.","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent C.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"McGeown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enno","family":"Christophers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Schmidtmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Guillaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Lamarque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Dubertret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0010","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2133.1997.tb02135.x","article-title":"Treatment of psoriasis with intermittent short course cyclosporin (Neoral). A multicentre study","volume":"136","author":"Berth-Jones","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0015","series-title":"Statistical Methods in Cancer Research, Vol. 2. The Design and Analysis of Cohort Studies","author":"Breslow","year":"1988"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0020","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0896-8411(89)80010-1","article-title":"The risk of neoplasms in patients treated with cyclosporin A","volume":"2","author":"Cockburn","year":"1989","journal-title":"J Autoimmun"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0025","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(97)08496-1","article-title":"Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimen","volume":"351","author":"Dantal","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0030","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2133.1995.tb05019.x","article-title":"The effect of severe psoriasis on the quality of life of 369 patients","volume":"132","author":"Finlay","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2133.1999.02655.x","article-title":"Malignant tumours and psoriasis: a follow-up study","volume":"140","author":"Frentz","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0040","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1046\/j.1365-2133.1999.03161.x","article-title":"Malignant tumours and psoriasis: climatotherapy at the dead sea","volume":"141","author":"Frentz","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0045","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/archderm.1996.03890300039008","article-title":"Long-term safety of cyclosporin in the treatment of psoriasis","volume":"132","author":"Grossman","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0050","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0190-9622(99)70148-9","article-title":"Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA","volume":"40","author":"Hannuksela-Svahn","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0055","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1523-1747.2000.00898.x","article-title":"Psoriasis, its treatment, and cancer in a cohort of Finnish patients","volume":"114","author":"Hannuksela-Svahn","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0060","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2133.1999.02977.x","article-title":"Intermittent short courses of cyclosporin for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study","volume":"141","author":"Ho","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0065","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1067\/mjd.2001.112400","article-title":"Intermittent short course of cyclosporin for the long-term management of plaque psoriasis: a 2-year cohort study","volume":"44","author":"Ho","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0070","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1046\/j.1365-2133.2000.03892.x","article-title":"Changing trends in non-melanoma skin cancer in South Wales, 1988\u201398","volume":"143","author":"Holme","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0075","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/(SICI)1097-0142(19970915)80:6<1141::AID-CNCR18>3.0.CO;2-8","article-title":"De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporin-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin","volume":"80","author":"Jonas","year":"1997","journal-title":"Cancer"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0140-6736(91)90083-2","article-title":"PUVA and cancer: a large-scale epidemiological study","volume":"338","author":"Lindel\u00f6f","year":"1991","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0085","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1365-2133.1999.02928.x","article-title":"PUVA and cancer risk: the Swedish follow-up study","volume":"141","author":"Lindel\u00f6f","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0090","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0140-6736(01)06179-7","article-title":"Squamous cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study","volume":"358","author":"Marcil","year":"2001","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0095","first-page":"778","article-title":"The risk of malignancy associated with psoriasis","volume":"137","author":"Margolis","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0100","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1046\/j.1365-2133.1999.03531.x","article-title":"Skin cancer in patients with psoriasis-many intertwined risk factors","volume":"141","author":"Murphy","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0105","series-title":"Cancer Incidence in Five Continents","first-page":"120","author":"Parkin","year":"1992"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0110","series-title":"Cancer Incidence in Five Continents","first-page":"143","author":"Parkin","year":"1997"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0115","series-title":"Psoriasis","first-page":"671","article-title":"Etretinate and acitretine: strategy for use and long-term side effects","author":"Paul","year":"1998"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0120","first-page":"320","article-title":"Risk of malignancy associated with cyclosporin use in psoriasis","volume":"198","author":"Paul","year":"1999","journal-title":"Dermatology"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0125","first-page":"23","article-title":"The problem of cancer in organ transplant recipients: an overview","volume":"4","author":"Penn","year":"1994","journal-title":"Transplant Sci"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0130","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0190-9622(98)70508-0","article-title":"Methotrexate in psoriasis: consensus conference","volume":"38","author":"Roenigk","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0135","series-title":"Anzdata registry","article-title":"Cancer report","author":"Sheil","year":"2001"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0140","first-page":"1129","article-title":"Risk indicators of de novo malignancy in renal transplant recipients","volume":"9","author":"Sloan","year":"1977","journal-title":"Transplant Proc"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0145","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2133.1997.tb01556.x","article-title":"A systematic review of five systemic treatments for severe psoriasis","volume":"137","author":"Spuls","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0150","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/archderm.135.7.843","article-title":"The mysteries of geographic variability in nonmelanoma skin cancer incidence","volume":"135","author":"Stern","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0155","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/archderm.134.12.1582","article-title":"Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis","volume":"134","author":"Stern","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0160","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM198405033101805","article-title":"Cutaneous squamous cell carcinoma in patients treated with PUVA","volume":"310","author":"Stern","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0165","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199704103361501","article-title":"Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study","volume":"336","author":"Stern","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0170","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/1523-1747.ep12292698","article-title":"Noncutaneous malignant tumors in the PUVA Follow-Up Study: 1975\u201396","volume":"108","author":"Stern","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2003.12040.x_bb0175","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/1529-0131(199811)41:11<1930::AID-ART6>3.0.CO;2-N","article-title":"No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis","volume":"41","author":"Van den Borne","year":"1998","journal-title":"Arthritis Rheum"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15301731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15301731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T03:57:09Z","timestamp":1553659029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15301731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["S0022202X15301731"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1747.2003.12040.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}